Cite
Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy.
MLA
Hamaï, Ahmed, et al. “Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy.” PLoS ONE, vol. 6, no. 6, June 2011, pp. 1–7. EBSCOhost, https://doi.org/10.1371/journal.pone.0021129.
APA
Hamaï, A., Duperrier-Amouriaux, K., Pignon, P., Raimbaud, I., Memeo, L., Colarossi, C., Canzonieri, V., Perin, T., Classe, J.-M., Campone, M., Jézéquel, P., Campion, L., Ayyoub, M., & Valmori, D. (2011). Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy. PLoS ONE, 6(6), 1–7. https://doi.org/10.1371/journal.pone.0021129
Chicago
Hamaï, Ahmed, Karine Duperrier-Amouriaux, Pascale Pignon, Isabelle Raimbaud, Lorenzo Memeo, Cristina Colarossi, Vincenzo Canzonieri, et al. 2011. “Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy.” PLoS ONE 6 (6): 1–7. doi:10.1371/journal.pone.0021129.